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ABSTRACT
We have demonstrated that cortical cell autografts
might be a useful therapy in two monkey models of
neurological disease: motor cortex lesion and Parkin-
son’s disease. However, the origin of the useful trans-
planted cells obtained from cortical biopsies is not
clear. In this report we describe the expression of
doublecortin (DCX) in these cells based on reverse-tran-
scription polymerase chain reaction (RT-PCR) and immu-
nodetection in the adult primate cortex and cell
cultures. The results showed that DCX-positive cells
were present in the whole primate cerebral cortex and
also expressed glial and/or neuronal markers such as
glial fibrillary protein (GFAP) or neuronal nuclei (NeuN).
We also demonstrated that only DCX/GFAP positive
cells were able to proliferate and originate progenitor
cells in vitro. We hypothesize that these DCX-positive
cells in vivo have a role in cortical plasticity and brain
reaction to injury. Moreover, in vitro these DCX-positive
cells have the potential to reacquire progenitor charac-
teristics that confirm their potential for brain repair.
J. Comp. Neurol. 519:775–789, 2011.
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Doublecortin (DCX) was first described in X-linked lis-
sencephaly and ‘‘double cortex’’ allelic human disorders
mapping to Xq22.3-Xq23. DCX is associated with arrest
of migrating cerebral cortical neurons (des Portes et al.,
1998; Gleeson et al., 1998). DCX was identified as the
microtubule-associated protein expressed by migrating
neuroblasts during a limited phase of their development
in both developing and adult mammals (Matsuo et al.,
1998; Francis et al., 1999; Gleeson et al., 1999; Brown
et al., 2003). DCX plays a crucial role for microtubule sta-
bilization (Gleeson et al., 1999) and nuclear translocation
during neuronal migration (Koizumi et al., 2006) as well
as in growth cone dynamics (Burgess and Reiner, 2000).
In the rodent nervous system, DCX expression is induced
in fast-dividing neuronal precursors, persists for 30
days, and is terminated thereafter as a consequence of
neuronal maturation (Brown et al., 2003). During the
important step of cell migration in neuronal development,
DCX participates in the regulation of microtubule dynam-
ics and stability during neuronal morphogenesis (Horesh
et al., 1999). In the adult brain it is now commonly
accepted that DCX is expressed in areas of neurogenesis,
indeed in the subventricular zone as well as the hippo-
campus. Outside these neurogenic niches, DCX was
previously thought to be almost absent (Omori et al.,
1998; Brown et al., 2003). However, more recently the
presence of DCX-positive cells was described in the cere-
bral cortex of guinea pig, cat, and primate, suggesting
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that these cells might be developing interneurons (Xiong
et al., 2008; Cai et al., 2009). Based on recent animal
studies, it is now conceivable that some precursor cells in
the human cortex proceed to the neuronal lineage (Jess-
berger et al., 2005). As a consequence, cells expressing
the marker of immature neurons (DCX) might be detecta-
ble in adult human neocortex and play a role, not as a
neurogenic marker, but in glia-to-neuron signaling media-
ting synaptic or metabolic plasticity (Verwer et al., 2007).
In human brain, some have argued in favor of the cru-
cial role of DCX in neuronal migration based on its expres-
sion in cytomegalic neurons and balloon cells in the corti-
cal lesions of tuberous sclerosis and focal cortical
dysplasia. These lesions show a disturbance in laminar
architecture and cell differentiation (Mizuguchi et al.,
2002). Since its pattern of expression is observed in
different neuronal developmental contexts, DCX has been
considered a possible internal indicator for neurogenesis
(Brown et al., 2003). Evidence from animal models indi-
cates that during injury, such as ischemic events or sei-
zure induction, the neurogenic response is associated
with the transient increased expression of DCX in adult
rodent brain (Arvidsson et al., 2002; Brown et al., 2003;
Couillard-Despres et al., 2005). Observations in rodents
during increased physical activities, environmentally
enriched conditions, or aging demonstrated that DCX was
closely correlated with the neurogenesis in two specific
brain structures: the subventricular zone (SVZ) and the
subgranular zone of the dentate gyrus (DG) (Brown et al.,
2003; Couillard-Despres et al., 2005; Rao et al., 2005).
Moreover, DCX continued to be expressed in many cells
of the adult rat telencephalon apart from the rostral mi-
gratory stream, especially in the corpus callosum and the
piriform cortex, suggesting that continuous migration of
neuronal precursors may still occur in these areas during
adulthood (Nacher et al., 2001). More recently, the pres-
ence of newly generated neurons has been described in
the adult rat paleocortex layer II (Pekcec et al., 2006;
Shapiro et al., 2007a,b). These cells appear to be gener-
ated during embryonic development mainly at embryonic
day (E)15.5 and persisted in the paleocortex layer II over
time (Gomez-Climent et al., 2008). DCX-positive cells
have also been described in the cortex layer II of the adult
guinea pig (Xiong et al., 2008). In nonhuman primate
piriform cortex and in the human olfactory bulb, newly
generated neurons are also observed by immunostaining
with other neurogenesis markers such as polysialylated
neural cell adhesion molecule (PSA-NCAM), beta-tubulin-
III, collapsin response mediator protein-4, neuronal
nuclear protein, and DCX (Bernier et al., 2002). The
presence of newly generated neurons was also described
in the primate striatum after a single injection of an
adenovirus vector expressing brain-derived neurotrophic
factor (BDNF) (Bedard et al., 2006). In human brain, a
recent study based on autopsy and surgically resected
tissue from 60 patients first reported the presence of
DCX-positive cells in the neocortex, where a minority of
them also expressed the astrocytic marker glial fibrillary
protein (GFAP) (Verwer et al., 2007).
The aims of the present study were to delineate the
DCX expression in primate neocortex, the distribution of
DCX-positive cells in the cerebral cortex, and to show
their potential link with the progenitor adult brain cells
obtained in culture from neocortical biopsies (Arsenijevic
et al., 2001; Brunet et al., 2002, 2003), a technique that
we have developed over a decade. This technique repre-
sents a new source of cells for transplantation since
these progenitors survive over time after reimplantation
and differentiate into neurons (Brunet et al., 2005). The
potential therapeutic impact is being evaluated for func-
tional recovery and brain repair in nonhuman primate
models of brain injury or neurodegenerative disease.
MATERIALS AND METHODS
This report is based on tissue from human and nonhu-
man primate brains. The pieces of cerebral cortex and
brains were obtained from three adult cynomolgus mon-
keys (Macaca fascicularis). Biopsies and brains were also
obtained from two adult African green monkeys (Chloro-
cebus sabaeus) from St. Kitts Biomedical Research Foun-
dation (St. Kitts-Nevis). Pieces of six brain resections
from human neurosurgery were obtained from trauma
(n ¼ 4) and epilepsy neurosurgeries (n ¼ 2) in accord-
ance with the local ethical committee of Lausanne
University Hospital. The animal tissues were obtained in
accordance with the Guide for Care and Use of Laboratory
Animals (ISBN 0-309-05377-3; 1996) and approved by
Swiss veterinary authorities, including the cantonal
Survey Committee on Animal Experimentation and the
Federal Veterinary Office (BVET, Bern, Switzerland).
Tissues from St. Kitts monkeys were obtained with the
approval of the St. Kitts’s Institutional Animal Care and
Use Committee (IACUC) and imported under an importa-
tion agreement (38925) under the Convention for Trade
in Endangered Species (CITES), although the St. Kitts
monkeys are not endangered.
Antibody characterization
The primary antibodies are described in detail in
Table 1. The four anti-DCX antibodies were raised against
a synthetic peptide (manufacturer’s technical informa-
tion), which corresponds to amino acids 385–402 of
human DCX. The manufacturer’s positive controls are
mouse brain lysate (Abcam, Cambridge, MA), hDCX:293T
and the human neuroblastoma SK-N-SH cell line lysates
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(Santa Cruz Biotechnology, Santa Cruz, CA) and rat brain
lysate (Millipore, Bedford MA; Chemicon, Temecula, CA).
For all four antibodies the peptides used were totally
homologous with the monkey sequences based on the
GenBank database (Macaca mulatta XM_001100519 and
Pongo abelii XM_002831997). All four antibodies against
DCX showed the same immunohistochemistry and were
confirmed by western blots. As expected, all these anti-
sera detected a 40–45-kDa band in human and monkey
brain cell lysates (Figs. 4 and S1).
The three anti-GFAP antibodies detected a 50–55-kDa
band in human and monkey brain cell lysates and stained
cells with the classic morphology and distribution of fibril-
lary astrocytes (Benton et al., 2008; Komitova et al.,
2009). The anti-Nestin antibody that was raised against a
recombinant protein corresponding to amino acids 1464–
1614 (Messam et al., 2000) detected a 200–220-kDa
band in human and monkey brain cell lysates. According
to the manufacturer’s information, the anti-vimentin poly-
clonal antibodies do not work for western blot but stained
cells with the classic morphology of glial progenitors
(Ponti et al., 2006; Pecchi et al., 2007).
The specificity of the secondary conjugated antibodies
was controlled by omitting the first antibody and crossre-
action was also verified. In brief, during the first incuba-
tion only one primary antibody was present, for example,
mouse anti-GFAP. The second incubation was done with
the corresponding species secondary antibodies against
mouse Ig, rabbit Ig, goat Ig, and guinea pig Ig conjugated
with Alexa 488, Alexa 597, and Alexa 680, with a counter-
staining of nuclei with DAPI. All secondary antibodies
were controlled for crossreaction through incubation
without primary antibody (Supplemental Data Fig. S2).
Production of in vitro adult human and
nonhuman primate brain cells
The 1-cm3 piece of resected cortex was washed three
times in phosphate-buffered saline (PBS) supplemented
with 33 mM glucose, 60 mg/L penicillin, and 100 mg/L
streptomycin. If delayed more than 2 hours before seed-
ing cells in culture, the brain samples were kept in Hiber-
nate A Medium (BrainBits, UK) at room temperature, as
lower temperatures were disadvantageous for viability.
Under a sterile environment, cortical tissue was washed
another three times in sterile PBS-glucose with antibiotics
and well orientated from the cortical surface to the white
matter, sliced with a razor blade to obtain enriched frac-
tions in the different gray matter (GM), and white matter
(WM) layers as shown in Figure 1.
For each slice, primary cultures were generated by
mincing and mechanically triturating the tissue with fire-
polished glass pipettes of decreasing diameters. Cells
were plated at 250,000 cells/cm2 in RPMI 1640 medium
(Gibco, Gaithersburg, MD) supplemented with glucose
25 mM, glutamine 2 mM, 10–20% preselected fetal
bovine serum (pFBS), and an antibiotic/antimycotic cock-
tail (A7292 Sigma-Aldrich, Buchs, Switzerland) directly on
a glass coverslip for immunocytochemistry or on plastic
dishes at 37C in a water-saturated atmosphere contain-
ing 6.5% CO2 / 93.5% air.
For each fraction, primary cultures were generated by
mincing and mechanically triturating the tissue with fire-
polished glass pipettes of decreasing diameters. Cells
were plated at 250,000 cells/cm2 in RPMI 1640 medium
(Gibco) supplemented with glucose 25 mM, glutamine
2 mM, 10–20% pFBS, and an antibiotic/antimycotic cock-
tail (A7292, Sigma-Aldrich) directly on a glass coverslip
TABLE 1.
Antigen Immunogen/peptide Species Catalog Number and Source
BrdU Bromodeoxyuridine conjugated
to bovine serum albumin
Mouse monoclonal
igG1 clone Bu20a
M0744, Dako, Glostrup, Denmark
DCX YLPLSLDDSDSLGDSM rabbit polyclonal IgG ab18723, Abcam, Cambridge, MA
DCX DLYLPLSLDDSDSLGDSM goat polyclonal IgG Sc-8066, Santa Cruz Biotechnology, California, USA
DCX YLPLSLDDSDSLGDSM guinea pig polyclonal IgG AB2253, Millipore, Billerica, Massachusetts, USA
DCX YLPLSLDDSDSLGDSM guinea pig polyclonal IgG AB5910, Millipore, Billerica, Massachusetts, USA
GFAP purified pig spinal cord GFAP Mouse monoclonal lgG1
clone GA5
G3893, Sigma-Aldrich, Buchs, Switzerland
GFAP Purified bovine GFAP Chicken polyclonal IgY AB5541, Millipore, Billerica, Massachusetts, USA
GFAP Purified cow spinal cord GFAP rabbit polyclonal IgG Z0334 DAKO, Glostrup, Denmark
Nestin 150 amino-acid nestin fragment
coupled to glutathione S-transferase
(Messam etal., 2000)
rabbit polyclonal IgG AB5922, Millipore, Billerica, Massachusetts, USA
NeuN Purified cell nuclei from mouse brain Mouse monoclonal lgG1
clone A60
MAB377, Millipore, Billerica, Massachusetts, USA
vimentin Purified porcine eye lens vimentin Mouse monoclonal lgG1
clone V9
M0725, Dako, Glostrup, Denmark
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for immunocytochemistry or on plastic dishes at 37C in
a water-saturated atmosphere containing 6.5% CO2/
93.5% air.
Observation of cultures with phase contrast micros-
copy or with light microscopy after fixation and staining
with hematoxylin revealed the same morphological char-
acteristics in human and nonhuman primary brain cell cul-
ture. Characterization was done by immunocytofluores-
cence for glial markers such as GFAP, vimentin, and
neural stem cell/progenitor markers such as nestin and
DCX.
Immunohistochemistry
Immunohistological staining was performed on 50-lm
thick formalin-fixed cryosections or 4-lm thick formalin-
fixed paraffin-embedded sections. Immunohistological
characterization was done for glial markers such as GFAP
and vimentin, neuronal markers such as neuronal nuclei
(NeuN), and neural stem cell/progenitor markers such as
nestin and DCX.
The immunoreactions were revealed with biotinylated
secondary antibodies followed by the immunoperoxidase
Vectastain Elite system (PK-6100, Vector Laboratories,
Burlingame, CA) and DAB substrate kit (SK-4100, Vector
Laboratories) and counterstained with Mayer’s hematoxy-
lin solution (MHS32, Sigma-Aldrich). The DAB immuno-
staining was observed under light microscope (BX40
Olympus) for DAB. The immunohistofluorescence was
performed with fluorescent dye conjugated secondary
antibodies. The macroscope images were obtained using
the Odyssey system (LI-COR, Bad Homburg, Germany)
that consists of scanning at 700 nm and 800 nm infrared
fluorescent dyes with a resolution of 21 lm per pixel. The
higher-magnification images were observed under an epi-
fluorescent microscope (IX81 Olympus) equipped with
FITC, Cy3, Dapi, and infrared 680 nm filters for multichan-
nel images that were acquired with two image analysis
programs (CellM, Olympus or MorphoPro, Explora-Nova).
To eliminate possible autofluorescence in cortex tissue
the sections were treated before slice mounting with a
solution of 1% Sudan Black II in a solution of 70% ethanol
(Fig. S2).
Histological observation and quantification
Drawings and cell counting of immunostained sections
were made with an Olympus BX40 epifluorescence micro-
scope equipped with a motorized X–Y-sensitive stage and
a video CDD camera connected to a computerized image
analysis system (Explora Nova, La Rochelle, France).
Images were acquired using three software programs
(Mosaic, Morpho Expert, and Fluo3D; Explora Nova) that
apply the same contrast and time exposition for acquisi-
tion to objectively compare series of staining. The images
were then generated in tiff format to be included in figure
with Adobe Photoshop CS4 (San Jose, CA). Representa-
tive 50-lm slices separated by 5 mm were used (seven
sections per animal, n ¼ 2). For each section, five cortical
columns were drawn and the layers were outlined for
each column. The threshold for DAB staining and the cell
surface limits from 50–500 lm2 were applied to auto-
matically identify all DCX-positive cells. The threshold of
Mayer nuclei staining and the limit of nuclei surface from
10–80 lm2 were applied to automatically identify all cells
(Mercator, Explora Nova). A visual control for these DCX-
positive cells and nuclei identifications was done on 20 of
260–300 fields per column. The obtained visual counts
confirmed the accuracy of the automatic counting
method for determining the percentage of DCX-positive
cells compared to total cells in the layers and columns.
Western blot
Total homogenates were obtained from human cortex
cryosections and held in RIPA lysis buffer (Santa Cruz Bio-
technology). The protein concentration was quantified
using the Pierce BCA Protein Assay Kit (Thermo Fisher
Scientific Waltham, MA). Ten lg were loaded per well on
Nupage 4–12% Bis Tris gel (Invitrogen, Life Technology,
Carlsbad, CA), run at 200V constant and transferred on
PVDF membrane (PerkinElmer, Zaventem, Belgium). The
Figure 1. Outline of the cortical slicing method. As described in
the text, the cortical biopsy was oriented from glia limitans to
white matter. It was then sliced parallel to the cortical surface
with a razor blade to obtain four or six layer-enriched fractions.
Each fraction was then separately minced and dissociated to
obtain cell cultures or to extract total RNA. In parallel, gray mat-
ter and white matter fractions were also minced and dissociated
as described previously (Brunet et al., 2002).
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membranes were first incubated in Odyssey Blocking
Buffer (OBB) (LI-COR), then with antibodies against
DCX (the same as for immunohistochemistry) and
Actin (Mouse AC74, Sigma-Aldrich), all diluted in OBB at
1/2,000. The membranes were then washed three times
in PBS for 10 minutes and incubated with appropriate
secondary antibodies conjugated with AlexaFluor 680
dye (Invitrogen, Life Technology) or with IRDye 800 (Rock-
land Immunochemicals, Gilbertsville, PA). After three
washes with PBS the membranes were scanned with the
infrared system Odyssey (LI-COR).
Reverse-transcription polymerase chain
reaction (RT-PCR)
Total RNA from fresh slice fractions and pellets of cells
was extracted with Trizol (Invitrogen) and 200 ng total
RNA was used for first strand synthesis using MulVRT-
M0253S (New England Biolabs, Beverly, MA) as described
by the supplier. PCR was performed with Polymerase Kit
(Qiagen, Chatsworth, CA) with 5 pmol of specific primers
per reaction. The specific primers for DCX and nestin
were designed to amplify the mRNA 1021–1494 (Access.
No. AJ003112) and 714–1433 (Access. No. X65964)
human sequences respectively and were homologous
for the corresponding 1021–1494 (Access. No.
XM_001100519) and 850–1567 (Access. No. AY650322)
monkey sequences. For actin mRNA as control, two
primer panels were used to amplify the 375–1154
(Access. No. X00351) human sequence and the 197–906
(Access. No. AB004047) monkey sequence. All specific
forward and reverse primers for RT-PCR were designed
on different exons to avoid any genomic contamination.
All PCRs were performed in the Personal Thermocycler
(Biometra, Germany) with one first denaturation step (3
minutes, 94C), followed by 35 cycles of denaturation
(94C, 30 seconds), annealing (60C, 30 seconds), and
elongation (72C, 60 seconds) and a final extension step
(72C, 10 minutes). The linearity of the amplifications
through 35 cycles was controlled as previously described
(Waselle et al., 2009). The infrared fluorescent nucleic
acid dye Syto60 (Molecular Probes, Eugene, OR) was
incorporated within the loading buffer (1/6,000) in order
to detect and quantify the amplicons with the Odyssey
infrared imaging system (LI-COR) after migration on a
0.8% agarose gel. To confirm the specificity of the mRNA
RT-PCR amplification, amplicons were subcloned with
pGEM-T easy vector system I (Promega, Madison WI) and
sequenced.
Incorporation of BrdU
The proliferation marker bromodeoxyuridine (BrdU;
Sigma-Aldrich) was used to investigate the specific phe-
notype of the proliferating cells. As positive controls, glio-
blastoma cell lines (LN308) were used in the same condi-
tions for BrdU incorporation as human and nonhuman
primate adult brain cell primoculture. At the three time-
points (6 days in vitro [DIV], 28 DIV, and 35 DIV) of the
cell culture, the adult brain cells were incubated 24 hours
before PAF fixation with a 5 lM final concentration of
BrdU added to the culture medium. The BrdU was
detected after a pretreatment with HCl 2N for 2 minutes.
The immunocytofluorescence was done with mouse anti-
BrdU antibody (744, Dako, Glostrup, Denmark), rabbit
anti-DCX antibody (ab18723 Abcam) and chicken anti
GFAP (AB5541, Chemicon) and the appropriate fluoro-
chrome conjugated secondary antibodies against mouse
Ig (Alexa 488, A-11032 Invitrogen, Life Technology), rab-
bit Ig (Alexa 594, A-11034 Invitrogen, Life Technology),
and chicken Ig (IRDye 700, 603-130-126, Rockland
Immunochemicals). The nuclei were counterstained with
DAPI. Immunostained cells were observed using an
epifluorescent microscope IX81 (Olympus).
Cell counting of BrdU-positive cells
Cell counting per coverslip was determined by the sum
of four fields on one coverslip. The total cell number was
determined by counting DAPI-counterstained nuclei. The
colocalization of BrdU with other markers such as GFAP
or DCX were done by co-immunocytofluorescence before
counting. The mean of cell number was established with
the six independent cell cultures from three patient
biopsies.
RESULTS
All data derived from the brain of two species of nonhu-
man primate (cynomolgus monkeys (Macaca fascicularis)
and St. Kitts green monkeys (Chlorocebus sabaeus) were
identical and therefore are presented below together.
DCX-positive cells are present in nonhuman
primate neocortex
In the nonhuman primate cerebral cortex, the immuno-
histochemical analysis showed that the expression of
DCX was not restricted to the subgranular zone of the hip-
pocampus or to the subventricular zone but DCX was also
found in the cerebral cortex (Fig. 2A). This DCX expres-
sion was highly localized at the glia limitans, in layer II
and layer V of the cortex (Fig. 2B–E). This expression was
also observed in human cortex and confirmed by compar-
ing three different sources of antibody against DCX
(Supplemental Data Fig. S1). The cell counting on
DAB-immunostained nonhuman primate brain sections
showed that 4.55 6 1.58% of total cells expressed DCX
in whole neocortex. In terms of percentage of positive
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Figure 2. DCX-immunohistochemistry done on macaque brain cryosection with guinea pig antibody against DCX (Chemicon). The mosaic
reconstruction (A) was a part of cerebral cortex in the right precentral gyrus at the level of superior precentral sulcus. (B–E) correspond
to boxes labeled (b to e) in (A): DCX was expressed in nonhuman primate cortex, in cells with long processes in the glia limitans and layer
I (B), in pyramidal cell bodies in layer II (C) and in layer V (D), and in small stellar cells at the border between GM and WM (E). The nuclei
were counterstained with Mayer’s hematoxylin solution (MHS32, Sigma-Aldrich). Note that this DCX distribution was through all the neo-
cortex with no significant difference in intensity or density. F: Distribution of DCX-positive cells in the cortical layers. The counts for DCX
and total nuclei were done in 35 cortical columns (5 columns per section, 7 sections per animal, n ¼ 2)) and in 12 areas of hippocampal
subgranular zone (HC) (3 areas per section, 4 sections). The first eight boxplots represent the distribution in the glia limitans, the six corti-
cal layers, and the white matter next to the gray. The ‘‘whole cortex’’ boxplot corresponds to the pooled counts in all layers. The results
are expressed in percentage of DCX-positive cells versus total nuclei. Note that there was no significant difference between cortical layers,
whereas there were significantly fewer DCX-positive cells (nearly 4-fold less) in cortical structures compared with the subgranular zone of
hippocampus (analysis of variance [ANOVA], Bonferroni multiple comparison ***P < 0.001). Scale bars ¼ 100 lm in A; 25 lm in B–E.
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cells, no significant differences were observed between
cortical structures or between cortical layers (Fig. 2F).
Furthermore, this percentage of DCX-positive cells is sig-
nificantly lower (near 4-fold) in cortical structures than in
the hippocampal subgranular zone, where 19.62 6 3.74%
of cells were DCX-positive. Higher magnifications showed
that the cells expressing DCX were not shaped homogene-
ously; indeed, DCX-positive cells with long processes were
observed in the glia limitans and in the layer I (Fig. 2B),
DCX pyramidal cell bodies with neuronal shapes were
stained in layer II (Fig. 2C) and V (Fig. 2D) and small stellar
DCX-positive cells were located at the limit between GM
and WM (Fig. 2E). The immunohistofluorescence to detect
Figure 3. Coronal sections of St. Kitts green monkey brain infra-
red immunostained for DCX (guinea pig antibody, Chemicon) and
GFAP or DCX and NeuN detected with Odyssey Infrared scanner
(LICOR) at a resolution of 21 lm per pixel. Fixed monkey brain
sections were cut in two half-sections, one incubated with guinea
pig anti-DCX and mouse anti-NeuN antibodies and the second
one incubated with guinea pig anti-DCX and rabbit anti-GFAP anti-
bodies followed by the appropriate infrared fluorochrome conju-
gated secondary antibodies (see Materials and Methods). The left
frontal cortex half-section was immunostained for DCX (in ma-
genta pseudocolor (A)) and NeuN (in green pseudocolor (C)) with
the overlay (B); the right frontal cortex half-section was immuno-
stained for DCX (in magenta pseudocolor (D)) and GFAP (in green
pseudocolor (F)) with the overlay (E). (G,I) Only the overlays
obtained as in (B) and (H,J) as in (E) for more caudal sections;
the green squares outline the subventricular zone in (G,H) and
the hippocampus in (I,J), respectively. Note that if the main DCX-
immunostaining is colocalized with NeuN, the glia limitans and
the limit between white and gray matter (white arrows) also
presents colocalization. Also note that DCX is detectable in whole
cortex from frontal to occipital lobes. Scale bars ¼ 1 cm.
Figure 4. Western blot done with three polyclonal antibodies
against DCX: (A) rabbit antibody (ab187723, Abcam); (B) guinea
pig antibody (AB2253, Chemicon); (C) goat antibody (sc-8066
Santa Cruz Biotechnology); and (D) actin (Mouse AC74, Sigma-
Aldrich). The western blot was done with one homogenate done
with normal adult human brain cortex biopsy (lane 1), and two
homogenates done from monkey brain obtained in vitro from the
WM and the GM fractions (lanes 2 and 3, respectively). L corre-
sponds to the SeeBlue ladder (Invitrogen).
Figure 5. RT-PCR done with total RNA extracted from human
neocortical layering slice-enriched fractions and from adult human
brain cell cultures. DCX mRNA was present in all fractions from
human cortex and in cell cultures from the first days in vitro
(DIV7) except in the meninges and in the deeper WM fraction
(slice 6). Nestin mRNA was not detectable under the same RT-
PCR conditions except slightly in the GM cell culture (DIV7). Actin
mRNA was used as control to establish the relative ratio of DCX/
Actin using Syto60 infrared intensity presented in the graph at
the bottom (this experiment is representative of the six slicing
experiments done with four human and two nonhuman primate
biopsies).
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DCX with the Odyssey infrared scanner showed that in
addition to expression in the subventricular zone (Fig. 3C)
and the subgranular zone of the hippocampus (Fig. 3D),
DCX was also observed in the whole cerebral cortex (Fig.
2). It confirmed the presence of DCX from glia limitans to
the limit between GM and WM in the nonhuman primate
neocortex. Similar results were obtained on the cryosec-
tions derived from the five normal monkeys (threeMacaca
fascicularis and two Chlorocebus sabaeus). The main corti-
cal expression of DCX was localized in the GM of the fron-
tal section (Fig. 3A,B). At this resolution rate of 21 lm, a
colocalization with NeuN could be observed at a macro-
scopic histological level in the cortical neuronal layers
(Fig. 3A), but also with GFAP in the glia limitans and at the
limit between GM and WM (Fig. 3B). This pattern of nonhu-
man primate cortical expression of DCX has been
observed through all the neocortex, even though the
expression was stronger in the subventricular zone and in
Figure 6. A: Mosaic reconstruction of the Chlorocebus neocortex triple immunofluorostaining for DCX (rabbit antibody, Abcam), NeuN and
GFAP detected with Alexa 488, Alexa 594, and IRDye 700 nm conjugated secondary antibodies, respectively, with a counterstaining of
nuclei with DAPI (in blue (A)). DCX (in magenta (B)) was mainly shown in layer I (white arrows), and in layers II and V (yellow arrows) even
if it was distributed from the glia limitans (white arrows) to the limit between gray and white matter. DCX immunostaining colocalized with
NeuN (in green (C)) (yellow arrows), and also with GFAP (in orange pseudocolor (D)) (white arrows). Scale bars ¼ 100 lm.
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the subgranular zone of the hippocampus (Fig. 3C,D). DCX
was expressed in whole cortex and the comparison of the
infrared DCX-immunolabeling intensities revealed no sig-
nificant difference between the different cortical areas.
The expression of DCX was also confirmed by western
blot (Fig. 4A–C) done with one adult human cortical ho-
mogenate and two monkey brain homogenates obtained
from WM and GM fractions, and the same bands were
revealed with rabbit (Abcam), guinea pig (Chemicon), and
goat (Santa Cruz) immunoglobulins against DCX (Fig. 4A–
C; note that D represents the actin expression as control
for western blot loading).
By RT-PCR done with the ‘‘slicing’’ procedure (Fig. 1),
the DCX mRNA was detected in the human neocortex,
with a significantly higher expression in slices 3, 4, and 5
that mainly corresponded to the topography of layer IV
and to the limit between GM and WM (Fig. 5). The specific
forward and reverse DCX primers were designed on
exons 3 and 7 of the human gene sequence, respectively;
the size corresponded to the DCX mRNA sequence. For
three RT-PCR samples (one human and two monkeys),
the amplicons were subcloned, sequenced, and con-
firmed the complete homology with the DCX sequence.
With the same samples, under the same RT conditions,
the PCR for nestin did not reveal the presence of nestin
mRNA in cortical slices. However a slight nestin expres-
sion was detected in the GM cell culture after 7 days.
DCX is expressed in astrocytes and
neurons in nonhuman primate cortex
To identify the cell subtypes of DCX-positive cells
revealed by immunohistochemistry, co-immunofluores-
cence labeling was performed using the rabbit antibody
against DCX (Abcam). The same pattern was observed
with this rabbit anti-DCX antibody compared to that from
the guinea pig (Fig. 6). The mosaic reconstruction of the
cortex exhibited the same layer distribution of DCX. Cell
counting on triple immunofluorescence-stained sections
gave the same percentage, 4.336 1.48% of DCX-positive
cells versus total cells in a cortical column as shown
above with DAB staining. Higher magnification demon-
strated the presence of four subpopulations of DCX-posi-
tive cells (Fig. 7). First, small cells only expressed DCX
and represented 17.85 6 4.32% of the total DCX-positive
cells. The cells that only expressed DCX presented long
processes and small nuclei. No co-localizations were
observed with Iba1 (microglia/macrophage marker), nes-
tin (neural progenitor/stem cell marker), or vimentin (glial
progenitor marker) (data not shown). Second, 26.24 6
3.31% of the DCX-positive cells coexpressed NeuN and
represented 2.89 6 1.18% of the total NeuN positive
cells. The DCX-positive cells that coexpressed NeuN in
layer I (Fig. 7A–D) presented the typical shape of the
Figure 7. Higher magnification of the Chlorocebus neocortex tri-
ple immunofluorostaining for colocalization of DCX (rabbit anti-
body, Abcam) revealed in green (A,E,I), GFAP in red (B,F,J), and
NeuN in orange pseudocolor (C,G,K) on 5-lm paraffin sections;
(D,H,L) show the overlays of (A–C), (E–G), and (I–K) respectively,
with the nuclei counterstained with DAPI in blue. Note that a sub-
population of DCX-positive cells coexpressed NeuN (yellow
arrows) in layer I (A–D), in layer II (E–H), and layer V (I–L);
another one coexpressed GFAP (red arrows) in the glia limitans
(A–D) and at the limit between GM and WM (I–L); a third one
coexpressed NeuN and GFAP (white arrows); and a fourth subpo-
pulation did not express NeuN nor GFAP (green arrow) in layer II
(E–H) and in layer V (I–L). (See also Supplemental Data Figs. S2,
S3.) Scale bars ¼ 50 lm.
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Cajal-Retzius cells (Fig. 8). In layers II and V the DCX-
NeuN positive cells exhibited a pyramidal neuronal shape
(Figs. 2, 7E–H). Third, 26.44 6 6.03% of the DCX-positive
cells coexpressed GFAP and represented 11.66 6 4.06%
of the total GFAP-positive cells. The DCX-GFAP positive
cells also presented two types of shape. In the glia limi-
tans, these DCX-GFAP-positive cells had long processes
but, at the border between GM and WM, they were small
stellar cells (Fig. 7I–L). Fourth, 29.47 6 7.07% of DCX-
positive cells surprisingly coexpressed NeuN and GFAP.
Notably, 92.856 5.80% of the total GFAP and NeuN-posi-
tive cells expressed DCX (Fig. 7).
DCX-positive cells are present in adult brain
cell cultures from human brain biopsies
The DCX mRNA was detected in adult human brain
cells from the first days in vitro when nestin was only
slightly or not detectable (Fig. 5). The immunocytofluores-
cence also revealed the presence of DCX in cells after
DIV 10. At different timepoints the progression of the cell
culture and the expression of DCX were investigated. The
cell quantification by infrared Syto 60 nucleus labeling
showed that only enriched cell suspensions that con-
tained DCX-positive cells, cortical slices 1 and 3, and the
WM and GM fractions were able to survive over time (Fig.
9J). Slice 4, which included a deeper cortical layer and
the limit between GM and WM, did not present viable
cells over time. Slice 2, which presented only few DCX-
positive cells at DIV 10, rapidly degenerated with no sur-
vival over time (Fig. 9D–F). Slices 1 and 3, the enriched
GM fraction and the enriched WM fraction that presented
DCX-positive cells, maintained a substantial population of
cells that survived over time and formed adult brain cell
aggregates (Fig. 9A–C,G–I).
The incorporation of BrdU revealed that some cells were
in S phase over 24 hours (Fig. 10). Fewer than 25 positive
cells per field were detected for BrdU from normal WM
and GM fractions. This number did not change over time
but the population continued to increase to a total of 45
cells per field at DIV 7, of 280 cells per field after 28 days.
At 35 days, the percentage of BrdU-positive cells only rep-
resented 9.8% despite 24 hours of exposure to BrdU (Fig.
10). Nearly all the BrdU-positive cells expressed DCX and
GFAP (white arrow, Fig. 10), although they were at the
metaphase stage of mitosis (yellow arrow, Fig. 10A–E).
The LN308 glioma cell line was used as the positive con-
trol for BrdU incorporation (Fig. 11) and showed that
69.2% per field of nuclei incorporated BrdU over 24 hours.
DISCUSSION
In the present study we demonstrated the expression
of DCX in the cerebral cortex of adult humans and two
species of monkeys. We discovered four different popula-
tions of DCX-positive cells. Indeed, the DCX-
Figure 8. The Chlorocebus neocortex triple immunofluorostaining on 50 lm floating prefrontal cortex cryosection for colocalization of DCX
(rabbit antibody, Abcam) in red (B), NeuN in green (C), and in the overlay (A) GFAP in orange with the nuclei counterstained with DAPI in
blue (A–D). The higher magnifications (B–D) show a cell that coexpressed NeuN and DCX (white arrows) and presented the typical shape
of the Cajal-Retzius cells. Scale bars ¼ 100 lm.
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immunoreactivity was localized in all the cerebral cortical
layers from the glia limitans and around the limit between
WM and GM. The DCX-positive cells had different shapes:
in layer I they presented the typical shape of the Cajal-
Retzius cells; in layers II and V they exhibited a pyramidal
neuronal shape. In the glia limitans they presented long
processes, whereas at the border between GM and WM
they were small stellar cells. We also demonstrated, using
mRNA and protein quantification, that DCX was detecta-
ble in all of the human neocortical tissues. The detection
Figure 9. Cell culture from neocortical layering slice enriched fractions immunostained for GFAP (in red) and DCX (guinea pig polyclonal
antibody, Chemicon) (in green) with a counterstaining of nuclei with DAPI (in blue). (A–C): slice 1 culture; (D–H): slice 2 culture; and (G–I):
slice 3 culture each shown at three different timepoints: DIV 10, 25, and 39. In slices 1 and 3 the presence of DCX-positive cells is
detected at all timepoints and the DCX population increases over time. After DIV 25, GFAP is just detected in a very few cells. (J): The
cell quantification done with the infrared DNA dye Syto60 showed that only enriched cell suspensions from slice 1, slice 3, WM and GM
fractions were able to survive over time. Note that these fractions contain DCX-positive cells in the early stage of culture. Scale bars ¼
50 lm.
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of DCX mRNA was performed by RT-PCR, which is more
sensitive than Northern blot (Omori et al., 1998).
Moreover, we demonstrated that the four DCX-positive
cell populations were colocalized, with different neuronal
and glial markers depending on their location in the cor-
tex: in layers I, II, and V the DCX-positive cells expressed
NeuN, whereas in the glia limitans and around the limit
between WM and GM the DCX-positive cells coexpressed
GFAP. In the glia limitans the DCX-positive cells with long
processes expressed GFAP and in the border between
GM and WM the small stellar DCX-positive cells also
expressed GFAP. The cells that only expressed DCX
presented long processes and small nuclei.
DCX-positive cells have been described in the neuro-
genesis niches of adult rodents (Brown et al., 2003; Couil-
lard-Despres et al., 2005; Rao et al., 2005), but they were
never detected in cortex except in the rat piriform cortex
where DCX was colocalized with NeuN, suggesting an
involvement in axonal or synaptic plasticity (Nacher et al.,
2001). Compared with total cell density, DCX-positive
cells were significantly less numerous in the cortex than
in the neurogenic subgranular zone of the hippocampus.
Nevertheless, DCX-positive cells in the cerebral cortex
represented a significant population, amounting to 4–
5% of all cortical cells. Furthermore, they were evenly
distributed among the four identified populations of DCX-
positive cells. This large distribution over the whole cortex
and subcortical areas would be related to the greater abil-
ity to elaborate interconnectivity between cortical struc-
tures in the more highly evolved simians and humans. We
hypothesize that this wide distribution of DCXþ cells may
have a close relationship with mammalian evolution, as
brain size has gradually increased (for review, see
Bradbury, 2005), in particular the cerebral cortex of the
more evolved species (for review, see Levitt et al., 1997).
Monkeys and humans have far more cortex than rodents,
and this enlarged cortex is associated with much slower
development (Allman et al., 1999). It may be that DCX
expression, which is a feature of immature neurons, is an
example of the retention of a juvenile trait of an ancestor
in the adults of the descendants, also known as a ‘‘pedo-
morphic’’ feature (Gould, 1992). The persistence of Cajal-
Retzius cells in adult human cerebral cortex as already
described (Martin et al., 1999) could also be another
argument for this hypothesis since some cells that coex-
press DCX and NeuN present the typical Cajal-Retzius
cell shape.
The evidence suggests now that the DCX cortical cells
are not stem cells, but they may have a neural progenitor
potential (Goldman et al., 1997; Palmer et al., 1999;
Bjorklund and Lindvall, 2000; Arsenijevic et al., 2001;
Brunet et al., 2002, 2005). These cells were certainly
present at the origin of the adult brain cell culture we
obtained in vitro with simian and human cortex; however,
this finding could not be reproduced with rodent brains,
where no DCX cortical cells could be detected. In this
report we demonstrate that the cells obtained in vitro
expressed DCX at the beginning of the culture. When the
cortex was sliced in layers, only the layers containing
DCX-positive cells were able to give viable cells over
time. The BrdU incorporation showed that only a few cells
were dividing and they expressed DCX and GFAP. The
number of dividing cells did not increase over time, which
suggests an asymmetric division. A dividing cell would
generate a quiescent progenitor cell that still expresses
DCX but not GFAP and a new dividing cell that expresses
DCX and GFAP. These proliferating cells were closely
associated with cells that have long GFAP-positive proc-
esses. This association of these cell types, which was
essential for the development of the culture over time,
should recreate the stem cell-like niche in vitro. This
niche, with few astrocytes that surround numerous DCX
and DCX/GFAP progenitors, represents an interesting
tool for cell therapy, since the astrocytes protect through
cell contact and ‘‘survival’’ factor delivery. We have al-
ready demonstrated the important rate of survival of such
cells after autologous reimplantation and their ability to
migrate and to differentiate into neurons in motor cortex
lesions in monkeys (Brunet et al., 2005) or to limit the TH
depletion in asymptomatic MPTP parkinsonian monkeys
(Brunet et al., 2009). These posttransplantation abilities
would also depend on the cell–cell interaction and the
progenitor properties of these cells as described in this
report.
In conclusion, the presence of DCX-positive cells and
the ability to produce precursor cell cultures from the
primate cortex were demonstrated to be closely linked,
even if the cellular origin of the in vitro cells has to be
Figure 10. Immunostaining for BrdU (in green), GFAP (in yellow pseudocolor), and DCX (rabbit antibody, Abcam) (in magenta) with a coun-
terstaining of nuclei with DAPI (in blue). A–E: WM cells in vitro (case 173 DIV35); F–J: GM cells in vitro (case 173 DIV28). These two pan-
els show the detection of BrdU (A,F), DCX (C,H), GFAP (D,I), and Dapi (B,G) and the overlay of the four color pictures (E,J). The BrdU-
positive cells from normal WM and GM fractions expressed DCX and GFAP (white arrows) even if they were at the metaphase stage of mi-
tosis (yellow arrow). K: Quantification at three timepoints of DCXþGFAPþBrdUþ cells compared to BrdUþ cells and total cells. Results
are expressed by means and standard deviations of cell number per field (n ¼ 3 cases, five fields were counted per case, ***P < 0.001,
the two last points compared to the first one). Nearly all BrdUþ cells were DCX- and GFAP-positive. Note that the number of BrdUþ cells
did not significantly increase over time unlike the total cell number. Scale bars ¼ 50 lm.
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Figure 10.
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clearly more clearly defined through further experiments.
This specificity of adult primate DCX expression in the
cortex is likely associated with the evolution of primate
cortex. These DCX-positive cells should be investigated
further to determine their roles in synaptic and metabolic
plasticity and various neuropathologies. In the future,
these cells could play an important role in brain repair as
endogenous tools or as autologous transplant material af-
ter in vitro cell culture, possibly with less tumor liability
and without immunogenicity.
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